Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,364 public trials 2,842 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

NCT02506933

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +43 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma

NCT01574274

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Children's Hospital Boston Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian New York, United States
  • Montefiore Medical Center New York, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors

NCT04432584

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Carolinas Healthcare System Charlotte, North Carolina, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • AZ Delta Campus Westlaan Roeselare, Belgium
View all 80 locations
View Trial Details
Active, Not Recruiting

Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy

NCT04140162

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Rochester Rochester, New York, United States
  • University of Texas Southwestern -- Simmons Comprehensive Cancer Center Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

NCT05757570

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +22 more
Locations
  • Investigational Site (230) Los Angeles, California, United States
  • Investigational Site (401) Washington D.C., District of Columbia, United States
  • Investigational Site (419) Cooper City, Florida, United States
  • Investigational Site (425) Miami, Florida, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

NCT04644575

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Orthopaedic Institute for Children Site Number : 8400003 Los Angeles, California, United States
  • Children's Hospital Los Angeles Site Number : 8400009 Los Angeles, California, United States
  • University of California San Diego Site Number : 8400007 San Diego, California, United States
  • University of Florida Health Site Number : 8400008 Gainesville, Florida, United States
View all 85 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

NCT05181618

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Orthopaedic Institute for Children Los Angeles, California, United States
  • University of Miami Medical Center Miami, Florida, United States
  • Oklahoma Children's Hospital ? Jimmy Everest Center Oklahoma City, Oklahoma, United States
  • Hospital das Clinicas - UNICAMP Campinas, São Paulo, Brazil
View all 28 locations
View Trial Details
Active, Not Recruiting

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

NCT05250037

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +14 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions